Valeris Expands Strategic Infrastructure with Launch of Transformation Office

Valeris™ Expands Strategic Infrastructure with Launch of Transformation Office

MORRISVILLE, NC & JEFFERSONVILLE, IN – Valeris announced today the establishment of its Transformation Office, a dedicated function designed to lead integration efforts following the transaction close between Mercalis and PharmaCord.

Created as a strategic investment into the future, Valeris’s Transformation Office ensures integration activities are managed through a focused enterprise-wide framework. By distinctly allocating responsibility for transformation independent from ongoing operational functions, Valeris is safeguarding uninterrupted, high-quality service while advancing its commitment to delivering lasting value for life sciences clients and advancing long-term growth and innovation.

“The Transformation Office reflects how we think about value, not just in outcomes, but in how we operate,” said Rob Truckenmiller, Chief Executive Officer, Valeris. “We are committed to delivering continuity for our clients, while building the infrastructure required to lead in a rapidly changing healthcare environment.”

As the regulatory landscape evolves and technology adoption accelerates across the healthcare landscape, Valeris is investing in infrastructure that enables long-term differentiation. The company’s Transformation Office is responsible for coordinating not only enterprise integration initiatives, but also cultural alignment and strategic planning.

“By decoupling integration from daily operations, we’re protecting what matters most – service delivery – while giving ourselves the strategic space to think and build for the future, said Patrick Lee, Chief Transformation Officer. “This represents a deliberate investment in transforming our organization, enabling us to innovate, enhance patient access solutions, and deliver sustained value to clients and patients alike.”

Joining the office as Vice President, Head of Merger Strategy, is Laura Obregon, who brings deep expertise in market access, pricing, contracting, and operational execution. Laura previously held leadership roles at EMD Serono across U.S. Oncology and Market Access and Patient Solutions, where she led high-impact strategic initiatives and enterprise transformation efforts.

“Laura brings a strong track record of translating strategy into results, fostering cross-functional alignment, and driving performance at scale,” said Patrick Lee. “Her ability to lead with clarity while cultivating an innovative, patient-centered culture is exactly what we need to move Valeris forward.”

Additional Transformation Office leadership includes:

• Dean Dimitropoulos, Vice President, Head of Merger Integration (formerly Vice President, Controller at PharmaCord)
• Staci McArter Galloway, Vice President, Head of Culture Strategy & Integration (formerly Director of Human Resources at PharmaCord)

**About Valeris **
Valeris is a fully integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company works on behalf of life sciences companies to improve the patient experience so that patients can access and adhere to critical medications. Backed by proven industry expertise, a deep commitment to patient care, the latest technology, and exceptionally talented team members, Valeris provides the data and strategic insights, patient support services and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Valeris provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina and Jeffersonville, Indiana. To learn more about Valeris, please visit www.valeris.com.

**Media Contact: **
Landy Townsend
VP, Marketing & Communications, Valeris
ltownsend@mercalis.com